PharmaEssentia Initiates Pivotal Trial of Ropeginterferon alfa-2b to Treat Essential Thrombocythemia

[Manouche]

« With a diversifying pipeline, the company is evaluating applications for pegylated interferon to address underserved hematologic cancers »

pharmiweb.com/press-release...

[AndyT]

This sounds like good news - logic dictates it should work and approval for use in ET as well as PV will be helpful 😊

[katiewalsh]

Do you know if this has been in use in the UK or EU? Thanks. Katie

[AndyT in reply to katiewalsh]

I think there has been approval for use in PV in the EU. Presumably any future approval for ET will have to be granted separately in EU and UK 😡

[katiewalsh in reply to AndyT]

Thanks. I thought it was in use there.

[EmeraldA]

Thanks for posting!

[jmctrek]

Thank you for this hopeful article.